Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoHypoplasia of the maxilla

IFIH1 BMP2 NEK1 RPS6KA3 CDH11 SON EFTUD2

2.22e-05130357HP:0000327
HumanPhenoAplasia/Hypoplasia of the maxilla

IFIH1 BMP2 NEK1 RPS6KA3 CDH11 SON EFTUD2

2.58e-05133357HP:0009117
MousePhenodecreased body length

BMP2 MFSD2A NEK1 USP42 RPS6KA3 PLXNA4 AUTS2 RREB1 CDH11 UNC80 SON

1.90e-064845411MP:0001258
MousePhenoabnormal body length

BMP2 MFSD2A NEK1 USP42 RPS6KA3 PLXNA4 AUTS2 RREB1 CDH11 UNC80 SON

6.50e-065505411MP:0001256
Domain-

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

3.20e-0667976133.30.160.60
Domainzf-C2H2

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

4.00e-066937613PF00096
DomainZnf_C2H2/integrase_DNA-bd

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

4.06e-066947613IPR013087
DomainZINC_FINGER_C2H2_2

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

1.33e-057757613PS50157
DomainZINC_FINGER_C2H2_1

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

1.37e-057777613PS00028
DomainZnf_C2H2-like

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

1.77e-057967613IPR015880
DomainZnf_C2H2

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

1.99e-058057613IPR007087
DomainZnF_C2H2

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

2.07e-058087613SM00355
Domainzf-C2H2_6

ZNF16 ZNF320 ZNF234 ZFP64 ZNF316 RREB1 ZNF649

2.88e-04314767PF13912
DomainDUF1220

NBPF4 NBPF6

5.77e-049762SM01148
DomainNBPF_dom

NBPF4 NBPF6

8.78e-0411762IPR010630
DomainNBPF

NBPF4 NBPF6

8.78e-0411762PS51316
DomainDUF1220

NBPF4 NBPF6

8.78e-0411762PF06758
DomainCadherin_CS

FAT1 PCDHA13 CDH11

9.98e-03109763IPR020894
DomainCADHERIN_1

FAT1 PCDHA13 CDH11

1.10e-02113763PS00232
DomainCadherin

FAT1 PCDHA13 CDH11

1.10e-02113763PF00028
DomainCADHERIN_2

FAT1 PCDHA13 CDH11

1.13e-02114763PS50268
Domain-

FAT1 PCDHA13 CDH11

1.13e-021147632.60.40.60
Domain-

COPA LRRK2 PLXNA4 WDR18 SON

1.15e-023337652.130.10.10
DomainCA

FAT1 PCDHA13 CDH11

1.15e-02115763SM00112
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

PPP1R8 ZNF16 ZNF320 MLEC USP42 PHF3 ZNF316 ZNF189 AUTS2 WDR18 PODXL2 FASTKD2 NDUFB3 RPL10 EFTUD2

7.54e-081203791529180619
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

XRN2 HIVEP2 ZNF234 ANK3 MLEC COPA AKAP17A AP2B1 MIB1 ZNF189 MAST1 EXOC7 PRRC2A ALPL CEP63

1.76e-071285791535914814
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

GRAMD1B XRN2 CAD MLEC COPA AP2B1 RPS6KA3 BCKDK WDR18 MCM2 PUM3 EXOC7 PRRC2A ALPL EFTUD2

7.46e-071440791530833792
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

XRN2 CAD ERP44 COPA AKAP17A AP2B1 USP42 BCKDK WDR18 PODXL2 RPL10 SON EFTUD2

9.38e-071082791338697112
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

SASH1 MAPT BCKDK PODXL2 BSN PRRC2A RPL10

1.01e-0623179716452087
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

XRN2 COPA AKAP17A PHF3 BCKDK WDR18 PUM3 EXOC7 PRRC2A RPL10 SON

1.17e-06759791135915203
Pubmed

Role of Indian hedgehog signaling in palatal osteogenesis.

BMP2 GLI1 ALPL

1.84e-061179321364421
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

XRN2 CAD COPA PHF3 RPS6KA3 MCM2 EXOC7 PRRC2A SON

2.16e-0650379916964243
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

XRN2 CAD COPA AP2B1 PHF3 WDR18 PUM3 PRRC2A RPL10 SON

2.29e-06653791022586326
Pubmed

The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.

MAPT LRRK2

5.09e-06279221898123
Pubmed

LRRK2 Promotes Tau Accumulation, Aggregation and Release.

MAPT LRRK2

5.09e-06279226014385
Pubmed

Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model.

MAPT LRRK2

5.09e-06279233007689
Pubmed

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.

MAPT LRRK2

5.09e-06279224113872
Pubmed

Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.

MAPT SLC1A2

5.09e-06279218992725
Pubmed

Nuclear Inhibitor of Protein Phosphatase 1 (NIPP1) Regulates CNS Tau Phosphorylation and Myelination During Development.

PPP1R8 MAPT

5.09e-06279236198882
Pubmed

MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.

MAPT LRRK2

5.09e-06279224559644
Pubmed

TNAP stimulates vascular smooth muscle cell trans-differentiation into chondrocytes through calcium deposition and BMP-2 activation: Possible implication in atherosclerotic plaque stability.

BMP2 ALPL

5.09e-06279227932058
Pubmed

USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication.

USP49 APOBEC3G

5.09e-06279231397674
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

XRN2 CAD COPA AKAP17A USP42 RPS6KA3 MIB1 MCM2 FASTKD2 RREB1 RPL10 SON EFTUD2

8.08e-061318791330463901
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

XRN2 COPA USP42 MAPT PHF3 MCM2 RREB1 PRRC2A SON EFTUD2

1.02e-05774791015302935
Pubmed

A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.

NBPF4 NBPF6 NBPF5P

1.46e-052179316079250
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

XRN2 CAD COPA AP2B1 WDR18 MCM2 RPL10 SON EFTUD2

1.46e-0563879933239621
Pubmed

Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

MAPT LRRK2

1.53e-05379223507417
Pubmed

Impaired glutamate transport in a mouse model of tau pathology in astrocytes.

MAPT SLC1A2

1.53e-05379216407562
Pubmed

LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth.

MAPT LRRK2

1.53e-05379222303461
Pubmed

A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor.

MAPT SLC1A2

1.53e-05379227456607
Pubmed

EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.

IFIH1 EFTUD2

1.53e-05379225878102
Pubmed

TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT.

MAPT LRRK2

1.53e-05379223664753
Pubmed

LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5.

MAPT LRRK2

1.53e-05379226268594
Pubmed

Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

MAPT LRRK2

1.53e-05379221816655
Pubmed

Inhibition of rhBMP-2-induced ALP activity by intracellular delivery of SMURF1 in murine calvarial preosteoblast cells.

BMP2 ALPL

1.53e-05379224288199
Pubmed

Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment.

ANK3 MAPT

1.53e-05379227356871
Pubmed

Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics.

MAPT LRRK2

1.53e-05379230571694
Pubmed

Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.

MAPT LRRK2

1.53e-05379225804954
Pubmed

Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.

MAPT LRRK2

1.53e-05379228202670
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

FAT1 ZNF234 ANK3 PHF3 PRRC2A ALPL SON

1.87e-0536179726167880
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

GRAMD1B CAD ANK3 COPA AP2B1 MAPT PLXNA4 MAST1 BSN NDUFB3 SLC1A2 PRRC2A RPL10

1.93e-051431791337142655
Pubmed

Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.

CAD COPA AP2B1 RPS6KA3 RPL10 EFTUD2

2.03e-0524479628902428
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

XRN2 PHF3 WDR18 MCM2 PUM3 CBLB PRRC2A RPL10 SON EFTUD2

2.20e-05847791035850772
Pubmed

Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways.

NEK1 LRRK2 CDC42EP3

2.50e-052579324947832
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

ZNF16 NEK1 FAT1 ERP44 USP42 PHF3 ZNF316 MIB1 RPL10

2.67e-0568979936543142
Pubmed

Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.

NEK1 FAT1 ERP44 RPS6KA3 ZNF316 WDR18 PUM3 EXOC7

2.90e-0553379825544563
Pubmed

Population genetics of apolipoproteins A-IV, E, and H, and the angiotensin converting enzyme (ACE): associations with lipids, and apolipoprotein levels in American Samoans.

APOA4 ACE

3.05e-05479215252864
Pubmed

Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2.

BMP2 ALPL

3.05e-05479215383550
Pubmed

Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains.

MAPT SLC1A2

3.05e-05479219527721
Pubmed

Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.

MAPT LRRK2

3.05e-05479224165324
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

PPP1R8 XRN2 CAD COPA WDR18 MCM2 PUM3 RPL10 SON

3.16e-0570479929955894
Pubmed

Proteomic analysis identifies novel binding partners of BAP1.

FAT1 CAD COPA EFTUD2

3.42e-058079434591877
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

XRN2 CAD WDR18 MCM2 PUM3 PRRC2A RPL10 SON EFTUD2

3.52e-0571479928302793
Pubmed

Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19.

IFIH1 ACE

5.07e-05579236672770
Pubmed

Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration.

MAPT GLI1

5.07e-05579229279401
Pubmed

Metalloprotease SPRTN/DVC1 Orchestrates Replication-Coupled DNA-Protein Crosslink Repair.

MCM2 SPRTN

5.07e-05579227871366
Pubmed

Discrete gene sets depend on POU domain transcription factor Brn3b/Brn-3.2/POU4f2 for their expression in the mouse embryonic retina.

MAPT GLI1 SLC1A2

5.34e-053279314973295
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

XRN2 CAD PHF3 ZFP64 ZNF189 RREB1 SON EFTUD2

5.46e-0558379829844126
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

FAM193A ANK3 AP2B1 KLF5 SPRTN BSN SON

5.67e-0543079735044719
Pubmed

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

MAPT BCKDK LRRK2

5.86e-053379325064009
Pubmed

Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.

XRN2 COPA AKAP17A MCM2 EFTUD2

6.12e-0518279532239614
Pubmed

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

CAD GPBP1L1 COPA AP2B1 RPS6KA3 ALPL

6.19e-0529879630737378
Pubmed

Sonic hedgehog is not required for polarising activity in the Doublefoot mutant mouse limb bud.

BMP2 GLI1

7.60e-0567929425131
Pubmed

Morphological evidence of the importance of epithelial tissue during mouse tongue development.

BMP2 GLI1

7.60e-05679214567981
Pubmed

Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.

MAPT RPS6KA3

7.60e-0567929546672
Pubmed

Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of Tau protein in vitro.

MAPT RPS6KA3

7.60e-0567929353289
Pubmed

Effect of cyclic mechanical stimulation on the expression of osteogenesis genes in human intraoral mesenchymal stromal and progenitor cells.

BMP2 ALPL

7.60e-05679224804200
Pubmed

Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes.

MAPT LRRK2

7.60e-05679224842889
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

XRN2 COPA USP42 PHF3 WDR18 MCM2 PUM3 RPL10 SON EFTUD2

8.07e-05989791036424410
Pubmed

Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.

ZFP64 MYO3B PCDHA13 C1GALT1 RREB1

8.07e-0519379522589738
Pubmed

Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement).

MCM2 PUM3 EFTUD2

8.29e-05377937584028
Pubmed

Kruppel-like factor 5 controls villus formation and initiation of cytodifferentiation in the embryonic intestinal epithelium.

BMP2 GLI1 KLF5

8.29e-053779323266329
Pubmed

Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways.

BMP2 TCN2 APOA4 ACE CDH11

8.89e-0519779521386911
Pubmed

Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.

CAD RPS6KA3 BCKDK WDR18 MCM2 RPL10 SON

8.99e-0546379727503909
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

XRN2 CAD ANK3 MLEC COPA AP2B1 ACE RPL10 EFTUD2

9.00e-0580779930575818
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

USP49 HIVEP2 ERP44 COPA AP2B1 USP42 WDR18 MCM2 PRRC2A EFTUD2

9.21e-051005791019615732
Pubmed

Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry.

MAPT RPS6KA3

1.06e-04779211181841
Pubmed

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.

MAPT LRRK2

1.06e-04779220711177
Pubmed

HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development.

BMP2 ALPL

1.06e-04779218160010
Pubmed

Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients.

NPHS1 ACE

1.06e-04779219520069
Pubmed

LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein.

MAPT LRRK2

1.06e-04779223190742
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

XRN2 CAD ERP44 COPA WDR18 MCM2 PUM3 RPL10 SON EFTUD2

1.07e-041024791024711643
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

COPA PHF3 RPS6KA3 RREB1 RPL10 EFTUD2

1.12e-0433279632786267
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

XRN2 CAD ERP44 ANK3 MLEC AP2B1 MCM2 FASTKD2 RPL10

1.26e-0484479925963833
Pubmed

Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1.

MCM2 PUM3 EFTUD2

1.30e-04437937584026
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

XRN2 CAD COPA AP2B1 MCM2 RPL10 EFTUD2

1.34e-0449479726831064
Pubmed

Noggin null allele mice exhibit a microform of holoprosencephaly.

BMP2 GLI1

1.41e-04879221821669
Pubmed

Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.

AUTS2 BSN

1.41e-04879219567891
Pubmed

Analysis of epithelial-mesenchymal interactions in the initial morphogenesis of the mammalian tooth.

BMP2 GLI1

1.41e-0487929769173
Pubmed

The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

MAPT RPS6KA3

1.41e-04879211311121
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

XRN2 CAD FAM193A AP2B1 PRRC2A RPL10 SON EFTUD2

1.55e-0467879830209976
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

XRN2 COPA USP42 PHF3 KLF5 ZFP64 WDR18 RREB1 RPL10 SON EFTUD2

1.61e-041294791130804502
Pubmed

Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily.

MAPT RPS6KA3

1.82e-04979217512525
Pubmed

G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development.

GLI1 ALPL

1.82e-04979232344102
Pubmed

Hedgehog-Gli activators direct osteo-chondrogenic function of bone morphogenetic protein toward osteogenesis in the perichondrium.

BMP2 GLI1

1.82e-04979223423383
Pubmed

Neutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization.

BMP2 ALPL

1.82e-04979231199918
Pubmed

The Wnt inhibitor, Dickkopf 4, is induced by canonical Wnt signaling during ectodermal appendage morphogenesis.

BMP2 GLI1

1.82e-04979217397822
Pubmed

Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities.

BMP2 GLI1

1.82e-04979215315763
Pubmed

TRIM46 Controls Neuronal Polarity and Axon Specification by Driving the Formation of Parallel Microtubule Arrays.

ANK3 MAPT

1.82e-04979226671463
Pubmed

Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.

NEK1 GPBP1L1 LRRK2 CBLB CDC42EP3

1.83e-0423079529513927
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

PPP1R8 NEK1 XRN2 GPBP1L1 ANK3 MLEC AP2B1 MCM2 RREB1 EXOC7 EFTUD2

1.93e-041321791127173435
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

GPBP1L1 PHF3 MAST1 BSN CDC42EP3

1.95e-0423379537704626
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SASH1 MLEC MIB1 AUTS2 MCM2 FASTKD2 BSN

2.04e-0452979714621295
Pubmed

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.

PPP1R8 NEK1 LRRK2

2.17e-045179324510904
InteractionAP2A2 interactions

GPBP1L1 AP2B1 MAPT RPS6KA3 MIB1 MCM2 EFTUD2

1.20e-05199787int:AP2A2
InteractionMRPS35 interactions

XRN2 USP42 BCKDK MAST1 FASTKD2 PRRC2A RPL10 EFTUD2

2.46e-05307788int:MRPS35
InteractionMRPS31 interactions

XRN2 USP42 MYO3B MAST1 FASTKD2 PRRC2A RPL10 EFTUD2

2.64e-05310788int:MRPS31
InteractionSTIP1 interactions

USP49 XRN2 CAD COPA AP2B1 MAPT RPS6KA3 BCKDK LRRK2 WDR18 MCM2 RPL10 SON EFTUD2

2.81e-0510067814int:STIP1
InteractionARHGEF7 interactions

MAPT GLI1 LRRK2 MAST1 CBLB EFTUD2

2.84e-05153786int:ARHGEF7
InteractionCNOT6L interactions

GPBP1L1 FAM193A ZSCAN1 MIB1 PRRC2A

3.04e-0593785int:CNOT6L
InteractionMRPS34 interactions

XRN2 USP42 MYO3B MAST1 FASTKD2 PRRC2A RPL10 EFTUD2

3.09e-05317788int:MRPS34
InteractionYWHAZ interactions

GRAMD1B NEK1 CAD GPBP1L1 HIVEP2 ERP44 SASH1 AP2B1 MAPT PHF3 LRRK2 MAST1 MCM2 PUM3 PRRC2A EFTUD2

3.74e-0513197816int:YWHAZ
InteractionYTHDF3 interactions

FAM193A KLF5 LRRK2 MCM2 PRRC2A RPL10 EFTUD2

4.69e-05246787int:YTHDF3
InteractionLRRK1 interactions

NEK1 GPBP1L1 LRRK2 CBLB CDC42EP3

4.74e-05102785int:LRRK1
InteractionNPM1 interactions

ZNF16 HIVEP2 ANK3 MAPT GLI1 RPS6KA3 WDR18 MCM2 PUM3 SPRTN PRRC2A RPL10 SON EFTUD2 CEP63

4.89e-0512017815int:NPM1
InteractionUFD1 interactions

MAPT LRRK2 MIB1 SPRTN PRRC2A EFTUD2

5.13e-05170786int:UFD1
InteractionHDAC6 interactions

FAT1 XRN2 CAD COPA AP2B1 MAPT GLI1 LRRK2 APOBEC3G MCM2 RPL10 ALPL EFTUD2

5.33e-059297813int:HDAC6
InteractionCTNND1 interactions

ANK3 MAPT RPS6KA3 MIB1 MCM2 CDH11 EFTUD2

7.49e-05265787int:CTNND1
InteractionRNF4 interactions

PPP1R8 ZNF16 ZNF320 MLEC AKAP17A USP42 PHF3 ZNF316 ZNF189 AUTS2 WDR18 PODXL2 FASTKD2 NDUFB3 RPL10 EFTUD2

8.43e-0514127816int:RNF4
InteractionILF2 interactions

XRN2 MAPT KLF5 MCM2 PUM3 FASTKD2 SPRTN RPL10 SON EFTUD2

9.01e-055907810int:ILF2
InteractionSRPK2 interactions

SLC39A12 XRN2 ZNF234 ANK3 AKAP17A MAPT PUM3 PRRC2A ALPL SON EFTUD2

9.51e-057177811int:SRPK2
InteractionHECTD1 interactions

XRN2 MLEC COPA AKAP17A PHF3 BCKDK WDR18 PUM3 EXOC7 PRRC2A RPL10 SON EFTUD2

9.54e-059847813int:HECTD1
InteractionFAM98B interactions

PPP1R8 XRN2 BCKDK MCM2 EFTUD2

1.03e-04120785int:FAM98B
InteractionTNRC6B interactions

GPBP1L1 FAM193A AP2B1 MAPT MIB1 PRRC2A CEP63

1.10e-04282787int:TNRC6B
InteractionRPL5 interactions

MAPT WDR18 MCM2 PUM3 FASTKD2 SLC1A2 PRRC2A RPL10 SON EFTUD2

1.12e-046067810int:RPL5
InteractionHDAC2 interactions

PPP1R8 CAD GPBP1L1 COPA AP2B1 GLI1 KLF5 RPS6KA3 RREB1 RPL10 ALPL EFTUD2

1.16e-048657812int:HDAC2
InteractionCTNNB1 interactions

USP49 CAD FAM193A ANK3 COPA MAPT KLF5 LRRK2 MAST1 MCM2 CDH11 RPL10 EFTUD2

1.23e-0410097813int:CTNNB1
InteractionMRTO4 interactions

CAD ZFP41 MAST1 PUM3 RPL10 EFTUD2

1.26e-04200786int:MRTO4
InteractionDHX58 interactions

IFIH1 XRN2 AP2B1

1.36e-0426783int:DHX58
InteractionMRPL15 interactions

XRN2 COPA MAST1 FASTKD2 PRRC2A RPL10

1.82e-04214786int:MRPL15
InteractionMRPS18B interactions

XRN2 KLF5 MYO3B MAST1 FASTKD2 RPL10 EFTUD2

1.86e-04307787int:MRPS18B
InteractionMRPL39 interactions

XRN2 LRRK2 MAST1 FASTKD2 RPL10 EFTUD2

1.91e-04216786int:MRPL39
InteractionEPS15L1 interactions

ANK3 AP2B1 MIB1 MCM2 CEP63

1.98e-04138785int:EPS15L1
InteractionMRPS14 interactions

XRN2 USP42 MAST1 FASTKD2 RPL10 EFTUD2

2.11e-04220786int:MRPS14
InteractionUBR5 interactions

USP49 XRN2 CAD AKAP17A MAST1 MCM2 SPRTN SON EFTUD2

2.13e-04533789int:UBR5
InteractionSHMT2 interactions

PPP1R8 XRN2 ERP44 COPA WDR18 PUM3 FASTKD2 SPRTN EXOC7 EFTUD2

2.56e-046717810int:SHMT2
InteractionFYN interactions

NPHS1 CAD MAPT RPS6KA3 CBLB RPL10 SON EFTUD2

2.60e-04431788int:FYN
InteractionCSNK2A1 interactions

GRAMD1B PPP1R8 XRN2 AKAP17A MAPT RPS6KA3 AUTS2 MAST1 MCM2 ACE RPL10 EFTUD2

2.92e-049567812int:CSNK2A1
InteractionYWHAE interactions

NEK1 CAD GPBP1L1 HIVEP2 SASH1 COPA MAPT LRRK2 MAST1 MCM2 FASTKD2 SPRTN PRRC2A EFTUD2

2.97e-0412567814int:YWHAE
InteractionHSP90AB1 interactions

ANK3 MAPT GLI1 RPS6KA3 BCKDK MYO3B LRRK2 MAST1 MCM2 SPRTN PRRC2A EFTUD2

3.04e-049607812int:HSP90AB1
InteractionMRPS27 interactions

XRN2 MAPT MAST1 FASTKD2 PRRC2A RPL10 EFTUD2

3.05e-04333787int:MRPS27
InteractionRPS17 interactions

MAPT KLF5 MAST1 MCM2 SPRTN RPL10 EFTUD2

3.28e-04337787int:RPS17
InteractionHSPH1 interactions

USP49 CAD MAPT RPS6KA3 LRRK2 MCM2 SPRTN EFTUD2

3.37e-04448788int:HSPH1
Cytoband1p13.3

NBPF4 NBPF6 NBPF5P

2.37e-04697931p13.3
CytobandEnsembl 112 genes in cytogenetic band chr19q13

NPHS1 ZNF320 ZNF234 ZSCAN1 SIGLEC16 HRC EMP3 ZNF649

1.03e-031192798chr19q13
CytobandEnsembl 112 genes in cytogenetic band chr7p22

USP42 ZNF316 C1GALT1

1.64e-03134793chr7p22
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649

5.05e-07718601328
GeneFamilyNeuroblastoma breakpoint family

NBPF4 NBPF6 NBPF5P

5.87e-0523603662
CoexpressionGRYDER_PAX3FOXO1_TOP_ENHANCERS

MFSD2A FAT1 SASH1 COPA AUTS2 MCM2 PODXL2 FASTKD2 CDC42EP3

6.51e-06441789M172
CoexpressionGSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN

CAD MLEC COPA BCKDK WDR18 MCM2

1.86e-05184786M6696
CoexpressionZHONG_PFC_C3_ASTROCYTE

ZNF320 ANK3 RPS6KA3 ZNF316 PLXNA4 AUTS2 MAST1 PODXL2

2.08e-05389788M39102
CoexpressionGSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP

IFIH1 ZNF16 ANK3 RPS6KA3 AUTS2 CBLB

2.51e-05194786M6595
CoexpressionGSE3982_CTRL_VS_LPS_4H_MAC_DN

IFIH1 HIVEP2 ERP44 SASH1 APOBEC3G SLC1A2

2.90e-05199786M5368
CoexpressionGSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP

GRAMD1B IFIH1 MIB1 ZNF189 RREB1 CBLB

2.98e-05200786M7417
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

MFSD2A FAT1 SASH1 COPA KLF5 AUTS2 MCM2 PODXL2 C1GALT1 FASTKD2 B4GALNT3 CDC42EP3

4.14e-0510097812M157
CoexpressionHEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS

ANK3 AP2B1 MAPT AUTS2 BSN

5.44e-05136785MM407
CoexpressionWELCSH_BRCA1_TARGETS_DN

CAD MLEC MCM2 PRRC2A SON

6.46e-05141785M2428
ToppCellCOPD-Epithelial-ATII|World / Disease state, Lineage and Cell class

BMP2 ANK3 KLF5 LRRK2 AUTS2 ALPL

9.06e-071837968e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCellCOPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

MFSD2A HIVEP2 ANK3 LRRK2 AUTS2 ALPL

1.03e-06187796030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 PUM3 ALPL

1.06e-06188796ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

XRN2 ANK3 AKAP17A USP42 PHF3 ACE

1.13e-0619079691ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellnormal_Lung-Epithelial_cells-AT2|normal_Lung / Location, Cell class and cell subclass

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.24e-0619379680ad1bdc50ecb8a50362f718248441cae20904a6
ToppCellhealthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

HIVEP2 ANK3 RPS6KA3 AUTS2 B4GALNT3 RPL10

1.35e-061967966eabbac1625f715531bae562a28da27664572600
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.43e-0619879619eefd05573fbaed654af52bf0f8a26092b8b229
ToppCelldistal-1-Epithelial-Alveolar_Epithelial_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.43e-06198796ce9d6b2a93c7b304414ce1b8b1a09562cf581278
ToppCellASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.43e-06198796ec0d1801363adb70c6a26655b79d12b438c7417d
ToppCelldistal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.48e-061997969086dbb60863c3da2cc5d0a310f28596a01c52ca
ToppCellBronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.48e-06199796a38a981cffa61c8444a980916de7414e689a1b63
ToppCelldistal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.48e-0619979621b44031bc5182ee23ba5e206042b2e5e4ee0c3c
ToppCelldistal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796a77087a393aad674d4aa457ca6c0077b0424053d
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-062007963c251ad03fbbdae91dfd9037880ba43adbb03807
ToppCelldistal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796f47bb79202a59404e4916993a1f59cffcf710320
ToppCellLung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796c2bde99b3bc7a8740441c1a0c1394892b940b857
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796c905451425d1c24773bb0ca69bcf0309b277d2f1
ToppCellParenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-0620079623088edc62bf7d4db890937bfd7925dc316fcc76
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-062007963ff9abd5e07780a59d5571da906fa15f00a1d5c2
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCellParenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796b2d61bc3afac0d78aa30082760da5b1a15d1fad2
ToppCellParenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCelldistal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796b0e5c8b425f47833cdc00b5aa3734c8c980f0967
ToppCellBronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCellParenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-0620079635c05cae30cd6b323d2662f1396ddeab08bc75fc
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type.

ANK3 MAPT PLXNA4 AUTS2 MAST1 CDC42EP3

1.52e-062007965b3df61ff421846ef4cabf1bd5355534c8b95509
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-0620079695b9cc2d6f18d8c3ece933e5537c16e1b7137b34
ToppCellParenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-062007969970e9bde6aa2ff3aef60dcb065ff15b7463e147
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BMP2 MFSD2A ANK3 KLF5 LRRK2 ALPL

1.52e-06200796eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass

NEK1 FAM193A SLC1A2 CDH11 EFTUD2

6.89e-06149795651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells)

BMP2 MFSD2A LRRK2 BSN ALPL

9.74e-06160795731def6d82814ebac1a400bc7aea5f6da43ec960
ToppCell390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells)

BMP2 MFSD2A LRRK2 BSN ALPL

9.74e-06160795cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor

FAT1 ANK3 KLF5 LRRK2 AUTS2

1.07e-05163795e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

MFSD2A ANK3 LRRK2 SLC1A2 ALPL

1.10e-05164795b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2
ToppCell367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

MFSD2A ANK3 LRRK2 SLC1A2 ALPL

1.10e-051647953aea6207a011ad55a1aeb2ed9fb54d31b23694b5
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

IFIH1 FAM193A USP42 LRRK2 ZNF649

1.31e-0517079507b561cd9c528bc8444c9385e1de621eee7b697e
ToppCellfacs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 TCN2 MAPT AUTS2 ALPL

1.59e-051777959c7c6824b9011363851f084a500d665f025b026e
ToppCellfacs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 TCN2 MAPT AUTS2 ALPL

1.59e-051777952bf639e9e801e5144462ffc957f5739e0dfcd500
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

MFSD2A ANK3 LRRK2 AUTS2 ALPL

1.72e-05180795198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class

NPHS1 BMP2 HRC CDH11 RPL10

1.81e-05182795354dcdb01360597f68c4fe157a682aee1c0b8bb1
ToppCellCOVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations)

MFSD2A ANK3 LRRK2 AUTS2 ALPL

1.91e-05184795369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCellIPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class

BMP2 MFSD2A ANK3 LRRK2 ALPL

1.96e-05185795563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCellIPF-Epithelial-ATII|World / Disease state, Lineage and Cell class

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.01e-051867956a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 PUM3 B4GALNT3

2.01e-05186795acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BMP2 MFSD2A LRRK2 PCDHA13 ALPL

2.07e-051877957c44cec1c26ca5907a495f2d7e633410e2e9728f
ToppCellCOPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class

BMP2 MFSD2A ANK3 KLF5 ALPL

2.12e-05188795eb6d79d733b53f64ca615bb777c64ed456866549
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.17e-05189795dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCellControl-Epithelial-ATII|Control / Disease state, Lineage and Cell class

BMP2 MFSD2A ANK3 KLF5 ALPL

2.23e-05190795d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 SLC1A2

2.29e-0519179534cc997e4e5c727495f321e6807a84aa124da486
ToppCell367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.29e-05191795d31975fc33779b0b3ff1a50d7c64fec8d08be4d4
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BMP2 MFSD2A LRRK2 RPL10 ALPL

2.29e-051917952b0d55a8e1b4ce862dd038f8e0429e8428fb8aba
ToppCellCOVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.29e-05191795276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 B4GALNT3

2.29e-05191795e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

MFSD2A ANK3 KLF5 LRRK2 B4GALNT3

2.34e-05192795499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCellEpithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.34e-0519279558c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.34e-05192795cc9911e182a289779a2612bc213daae5607689e7
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.34e-0519279506013a07e3a873b1d1c0451643c528593ac32a9c
ToppCellAdult-Epithelial|Adult / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 B4GALNT3

2.34e-05192795efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.40e-05193795fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.40e-05193795738f4f0a9ddde2432b429ab46838e353b1790589
ToppCellAT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

MFSD2A ANK3 MAPT LRRK2 ALPL

2.40e-051937958187f976fd2d11fad3286690f1a046e894772220
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.40e-05193795f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell(1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis

FAT1 PODXL2 EMP3 CDH11 ALPL

2.40e-05193795035eeea9f77c4bf9cd85f07fa791b6c857be76b5
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.46e-0519479597534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCellControl-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

BMP2 MFSD2A LRRK2 AUTS2 ALPL

2.46e-05194795a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCellnormal_Lung-Epithelial_cells-AT2|Epithelial_cells / Location, Cell class and cell subclass

BMP2 MFSD2A LRRK2 RPL10 ALPL

2.52e-0519579581e13fe337f1d0a83d0deb86a0df797d306cd24d
ToppCellnormal_Lung-Epithelial_cells|normal_Lung / Location, Cell class and cell subclass

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.52e-051957957c90d887afde5c4d63352b5171be9987e2dfca58
ToppCellControl-Epithelial|Control / Disease state, Lineage and Cell class

BMP2 ANK3 KLF5 B4GALNT3 ALPL

2.52e-051957951798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MFSD2A FAT1 ANK3 KLF5 MYO3B

2.52e-051957953d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BMP2 MFSD2A ANK3 LRRK2 ALPL

2.59e-051967957e5addaa844e66f8160e05858c341866a80aed23
ToppCellASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

BMP2 MFSD2A ANK3 LRRK2 ALPL

2.59e-05196795754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MFSD2A LRRK2 CDH11 RPL10 ALPL

2.59e-05196795988a3e0688e0a7ba69774497d3b130631bb26c50
ToppCellLAM-Epithelial-AT2|LAM / Condition, Lineage and Cell class

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.59e-051967959165041ef3d56b4d069497fee03dd1c6e273211d
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BMP2 MFSD2A LRRK2 RPL10 ALPL

2.59e-05196795fa42a8f8a11645fc733ce9c59c2a0599ecf2176d
ToppCellLAM-Epithelial|LAM / Condition, Lineage and Cell class

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.65e-05197795e5cf07061f6d9db7f12ac17209b267373fa2270b
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BMP2 MFSD2A ANK3 LRRK2 ALPL

2.65e-05197795bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCellmedial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.72e-05198795102a4cbb138adbfba11ed955420095daa098532f
ToppCellAT2_cells|World / lung cells shred on cell class, cell subclass, sample id

BMP2 MFSD2A KLF5 LRRK2 ALPL

2.72e-0519879592c569c3b8a9fca2d4682cbf77ee8149bcc0a80a
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.72e-051987957caeed2d5dc78866023c8f38edcec9886baa9f2c
ToppCelldistal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TAGAP LRRK2 APOBEC3G WDR18 RPL10

2.72e-051987953ee0bd36a01765dca9318a6c9b9be4898f7d56fa
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 LRRK2 ALPL

2.72e-05198795de5748c2b66ecc432974cf095ecd241369579f7c
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MFSD2A ANK3 LRRK2 AUTS2 ALPL

2.72e-051987952e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.72e-0519879553e5d76831d70b9a476f3ef3a81e13eda974d543
ToppCellBiopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.78e-051997959a65acfe9bf500db72142469cf17bf0973540001
ToppCellEpithelial_cells|World / lung cells shred on cell class, cell subclass, sample id

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.78e-05199795bbe69e44b7970f57628365ae771790f2b13d0cae
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

ANK3 AP2B1 MAPT PLXNA4 RPL10

2.78e-051997951b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCellASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

BMP2 MFSD2A ANK3 KLF5 LRRK2

2.78e-05199795ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7
ToppCellBiopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

BMP2 MFSD2A KLF5 LRRK2 ALPL

2.78e-051997955323d49d3be980605b3e609b7f03bddba6e50e8a
ToppCellNeuron|World / Primary Cells by Cluster

ANK3 MAPT PLXNA4 AUTS2 RPL10

2.78e-051997951f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.78e-05199795e459d5aa63c83f960562be33cea8182b0556eabf
ToppCellNeuron-Postmitotic|World / Primary Cells by Cluster

ANK3 MAPT PLXNA4 AUTS2 RPL10

2.78e-051997951973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

ANK3 AP2B1 MAPT PLXNA4 RPL10

2.78e-051997954bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.78e-05199795e28ace2ca680c6154398e17110aa1838dd7a5548
ToppCellNeuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster

HIVEP2 ANK3 MAPT PLXNA4 AUTS2

2.78e-05199795058373b4ac3cec2108cb24265628ff0a50646e33
ToppCellproximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BMP2 MFSD2A ANK3 LRRK2 ALPL

2.85e-052007957bd76884fcffdbd9b8d24f5b6b5187ad3963da5f
ToppCell10x_5'_v1-Non-neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TAGAP APOBEC3G CBLB RPL10 SON

2.85e-0520079588e94b067da1068b2ff1f95c730f2a49c66d7fe6
ToppCellcellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.85e-05200795e4204c4b864346f47d76b0f0faae96f04fed5082
ToppCelldistal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.85e-052007950a97080f694738bb882787cee21b91a4d5757b7a
ToppCellproximal-Epithelial|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.85e-052007953790dd13c4ff471e716e5a2950f196e3c386dbb1
ToppCellproximal-3-Epithelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MFSD2A ANK3 KLF5 LRRK2 ALPL

2.85e-0520079508858bb20630849ffb2192631e23466c242a1078
Diseasenephrotic syndrome (implicated_via_orthology)

NPHS1 FAT1 ACE

3.07e-0524753DOID:1184 (implicated_via_orthology)
DiseaseProgeria

ANK3 SPRTN

6.34e-055752C0033300
Diseasemicrocephaly (implicated_via_orthology)

MFSD2A AUTS2 EXOC7

7.42e-0532753DOID:10907 (implicated_via_orthology)
DiseaseAttached earlobe

HIVEP2 MYO3B

1.77e-048752HP_0009907
Diseaseschizophrenia (is_marker_for)

ANK3 APOA4 ACE

1.94e-0444753DOID:5419 (is_marker_for)
Diseaseautoimmune thyroid disease

IFIH1 SASH1 CBLB SLC1A2

3.05e-04126754EFO_0006812
DiseaseLiver carcinoma

MFSD2A MAPT GLI1 RPS6KA3 MCM2 SPRTN ACE

3.07e-04507757C2239176
DiseaseAbnormality of refraction

GRAMD1B BMP2 MFSD2A ANK3 MAPT AUTS2 PCDHA13 C1GALT1

3.09e-04673758HP_0000539
Diseaseouter ear morphology trait

HIVEP2 MYO3B

4.14e-0412752EFO_0007664
DiseaseAlzheimer's disease (implicated_via_orthology)

HIVEP2 MAPT ACE

4.18e-0457753DOID:10652 (implicated_via_orthology)
Diseasejuvenile polyposis syndrome (implicated_via_orthology)

BMP2 HIVEP2

4.88e-0413752DOID:0050787 (implicated_via_orthology)
Diseaseadvanced glycosylation end product-specific receptor, soluble measurement

KLF5 B4GALNT3

4.88e-0413752EFO_0020131
Diseaseintermediate coronary syndrome (is_marker_for)

APOA4 ACE

4.88e-0413752DOID:8805 (is_marker_for)
Diseaselobe size

HIVEP2 MYO3B

5.69e-0414752EFO_0007666
Diseaseneutrophil count

IFIH1 SLC39A12 HIVEP2 COPA TAGAP MAPT KLF5 ZNF316 PCDHA13 NBPF6 RREB1

7.12e-0413827511EFO_0004833
Diseaseautosomal recessive polycystic kidney disease (implicated_via_orthology)

NEK1 ACE

7.48e-0416752DOID:0110861 (implicated_via_orthology)
DiseaseParkinson's disease (is_implicated_in)

TCN2 MAPT LRRK2

9.70e-0476753DOID:14330 (is_implicated_in)
Diseasetype 1 diabetes mellitus (is_implicated_in)

ACE CBLB PRRC2A

1.34e-0385753DOID:9744 (is_implicated_in)
DiseaseAutosomal Recessive Primary Microcephaly

MFSD2A CEP63

1.42e-0322752C3711387
DiseaseParkinson disease

MAPT LRRK2

1.42e-0322752cv:C0030567
DiseaseOvarian Serous Adenocarcinoma

LRRK2 MAST1

1.56e-0323752C1335177
DiseaseAlbuminuria

NPHS1 ACE

1.70e-0324752C0001925
Diseasechronotype measurement

FAM193A ANK3 AP2B1 MAPT KLF5 PLXNA4 AUTS2 BSN

1.78e-03882758EFO_0008328
DiseaseDepressive Symptoms

AP2B1 ACE

1.99e-0326752C0086132
DiseaseThyroid preparation use measurement

IFIH1 SASH1 CBLB SLC1A2

2.30e-03217754EFO_0009933
DiseaseAutosomal Dominant Parkinsonism

MAPT LRRK2

2.31e-0328752C0752098
DiseaseAutosomal Dominant Juvenile Parkinson Disease

MAPT LRRK2

2.31e-0328752C0752097
DiseaseParkinsonism, Experimental

MAPT LRRK2

2.31e-0328752C0752101
DiseaseAutosomal Recessive Parkinsonism

MAPT LRRK2

2.31e-0328752C0752100
DiseaseFamilial Juvenile Parkinsonism

MAPT LRRK2

2.31e-0328752C0752104
DiseaseRamsay Hunt Paralysis Syndrome

MAPT LRRK2

2.31e-0328752C0242423
DiseasePARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE

MAPT LRRK2

2.31e-0328752C1868675
Diseasesleep duration

USP49 NEK1 MAPT MYO3B AUTS2

2.31e-03362755EFO_0005271
Diseaseamyotrophic lateral sclerosis (is_marker_for)

LRRK2 SLC1A2

2.48e-0329752DOID:332 (is_marker_for)
DiseaseAmyotrophic Lateral Sclerosis With Dementia

NEK1 SLC1A2

2.48e-0329752C0393554

Protein segments in the cluster

PeptideGeneStartEntry
FVEGSHGIHRKHLPI

AP2B1

581

P63010
HSHGPQFGSEVELRH

ACE

1291

P12821
HIHFPAGVIDAIRKH

B4GALNT3

881

Q6L9W6
APHKHGFLEGRHAEL

APOBEC3G

246

Q9HC16
HHLALHEDKPDFVGI

BCKDK

206

O14874
TFGHDGKGHPLHKRE

BMP2

266

P12643
GDFRHTIHIGKEGQH

CDC42EP3

36

Q9UKI2
VFHGISKEDHRHSAP

FAM193A

646

P78312
PTDEDVGHRIKHVAG

GRAMD1B

586

Q3KR37
GHEHGHHKMELPDYR

NDUFB3

6

O43676
GHRLAEHLVHKLSPE

NBPF4

151

Q96M43
GKDGELHIAEHPAGH

PUM3

541

Q15397
GSHVRHHPSNKEEEG

MCM2

681

P49736
PHAGDVEGHLSFLEK

APOA4

331

P06727
LVEEVLPRHGSGHHG

PODXL2

416

Q9NZ53
KEHHEHFQIGPLGEI

FAT1

2121

Q14517
EGDPARGEFHLHIEA

NPHS1

86

O60500
AAGHHHFPDADDIRK

NEK1

491

Q96PY6
FEKHGEHLPRGEGRF

GPBP1L1

26

Q9HC44
DVHGIHFRKDPLEGR

MLEC

61

Q14165
AITHHVKEGHEKADP

RPS6KA3

51

P51812
HDEGGPGRHASAKEH

BSN

3631

Q9UPA5
EIHHRKPHGPEAALE

CBLB

916

Q13191
DEQADKHGIHDPHVR

PLXNA4

1721

Q9HCM2
AKEGHLPEKDGHGHE

AUTS2

911

Q8WXX7
EKIGDEDGHFPAHRE

LRRK2

386

Q5S007
VHGPDAHVTKRHRGD

GLI1

386

P08151
ISPGHEHDFRVKHLS

EXOC7

326

Q9UPT5
SLEVGHPDFRKDFHG

MAST1

1286

Q9Y2H9
HPDFRKDFHGELALH

MAST1

1291

Q9Y2H9
DKDGDTPLHEALRHH

MIB1

696

Q86YT6
DAPHHRLLVLVKDHG

PCDHA13

641

Q9Y5I0
DVIDDFHLKQPHFHG

MFSD2A

421

Q8NA29
VEGGRIDHGHHEGKA

ALPL

331

P05186
EFKPTHGQHRHDGIK

CEP63

556

Q96MT8
KFDEHDGPVRGIDFH

COPA

46

P53621
SHLGSEEPKHRHLGL

SLC1A2

21

P43004
AHHLIGAGHSSEFKP

IFIH1

751

Q9BYX4
LRPSFHGHHEKGKEG

CDH11

31

P55287
HDVRENHIGHPESKS

ANK3

2876

Q12955
LHSGKLHREFHHGPD

ERP44

351

Q9BS26
IGKETFHPFVPEHHL

C1GALT1

261

Q9NS00
HAEEILEKHPRGGSF

EMP3

121

P54852
GLHKQEAPEFGHFHE

SLC39A12

426

Q504Y0
EAPEFGHFHESKGHI

SLC39A12

431

Q504Y0
THGTFLGHIRLEPHK

PPP1R8

91

Q12972
HHVEDSRHRGSKEPL

TAGAP

641

Q8N103
GHRLAEHLVHKLSPE

NBPF5P

151

Q86XG9
GHRLAEHLVHKLSPE

NBPF6

151

Q5VWK0
GKDGFHIRVRLHPFH

RPL10

81

P27635
LGGEGHFSKDVHLPH

FASTKD2

586

Q9NYY8
DELEGPDSKLHHGHD

PRRC2A

216

P48634
KHLLGAEHGDEPRHG

WDR18

341

Q9BV38
HLLPGHRSQDHKVGD

HRC

101

P23327
EDEKRAIGHDHKGHP

TCN2

136

P20062
KPDDSHTHDELGVAH

AKAP17A

446

Q02040
HQRIHTGERPHKCGE

ZNF189

306

O75820
PFHGGREHERAGLHE

USP42

1076

Q9H9J4
DHIRHQRVHTGEKPF

ZFP41

101

Q8N8Y5
HRRIHTGEKPHKCGD

ZNF320

431

A2RRD8
EDRERKGSIPFHHTG

UNC80

451

Q8N2C7
EHGRGESHEPEEEHG

RREB1

1326

Q92766
HFIEHQKTHREEGPF

ZSCAN1

306

Q8NBB4
GDVLFVGKHHPLHDF

XRN2

681

Q9H0D6
EDHALKHFEETGHPL

USP49

51

Q70CQ1
SHVKEELEHPGVEHF

PHF3

641

Q92576
TPLEGHRKGHEFEGT

SASH1

946

O94885
HRKGHEFEGTHHPLG

SASH1

951

O94885
EDTEGGRHAPELLKH

MAPT

176

P10636
HVHLREPGGTHKEDF

CAD

1471

P27708
DREGHGPEFCKHMHR

SPRTN

126

Q9H040
SVGHHPFKHDVFLLE

ZNF234

46

Q14588
HLAAHVRGHTGEKPF

ZNF316

761

A6NFI3
KHHRTHTGEKPFECG

ZNF16

366

P17020
GDHDDDHPGMEVVLH

EFTUD2

46

Q15029
GHENLSHGHTERFDP

HIVEP2

746

P31629
DLDRHLRIHTGDKPH

ZFP64

316

Q9NTW7
ALHSGEEPHAEEHLK

SON

1506

P18583
LLVHDSGPDHRKHFL

SON

2391

P18583
EHEGEFTCHARHPLG

SIGLEC16

401

A6NMB1
LTEHERAHRGEKPHG

ZNF649

221

Q9BS31
FPGEELKHAHHRPQA

KLF5

46

Q13887
HLLDHPFIKGVHGKV

MYO3B

286

Q8WXR4